President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He Succeed?
Raymond J. March • Wednesday, February 10, 2021
When Healthy Policy Neglects Economic Principles, Patients Suffer
Raymond J. March • Saturday, October 13, 2018
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond J. March • Wednesday, September 12, 2018
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond J. March • Friday, June 22, 2018
One Solution to the EpiPen Crisis: Repeal Durham-Humphrey!
John R. Graham • Tuesday, September 27, 2016